StocksRunner logo
mail
search
 
menu
 
CRISPR Therapeutics
33.16
-11.86%
 
  Overview  
  
  Analysis  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
 
 

CRSP

 

CRISPR Therapeutics

$33.16

 
-$4.46 | -11.86%
 
  Overview  
  
  Analysis  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
Open
$ 36.92
 
 
MKT CAP
$ 2.87B
 
High
$ 36.97
 
 
VOL
$ 3.22M
 
Low
$ 33.03
 
 
AVG VOL
$ 2.18M
 
 
 

Chart

 
 

39.18

39.62

40.94

54.76

 
 
1year
6month
3month
1month
 
CRSP Latest Headlines +
 
 
 
StocksRunner

Explore our CRSP Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored CRSP Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our CRSP Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner
Overview
 
StocksRunner
Trending
 
StocksRunner
Screener
 
StocksRunner
Ideas
 
StocksRunner
Top Rated
 
StocksRunner
Momentum
 
StocksRunner
Earnings
 
 

Recently Viewed

 

CRSP

CRISPR Therapeutics

 
 
 
Top Banner
 
  Overview  
  
  Analysis  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 
 
 

CRSP

 

CRISPR Therapeutics

$33.16

 
-$4.46 | -11.86%
 

 

Chart

 
 

39.18

39.62

40.94

54.76

 
 
1year
6month
3month
1month
 
 
 
 

CRSP Latest Headlines

 
 
 

CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts.

 

Mon May 5, 2025

 
Potential

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts. CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.25 moving 1.38% from the previous trading session.

 

Fri May 2, 2025

 
Momentum

[Latest] Global Regenerative Medicine Market Size/Share Worth USD 248.73 Billion by 2034 at a 19.2% CAGR: Custom Market Insights (Analysis Outlook Leaders Report Trends Forecast Segmentation Growth Growth Rate Value). Regenerative Medicine Market Size Trends and Insights By Product (Serum-free Media Classical Defined Media Stem Cell Culture Media Specialty Media Chemically Defined Media Other Cell Culture Media) By Type (Liquid Media Semi-solid Media Solid Media) and By Region - Global Industry

 

Mon Apr 28, 2025

 
Activity
Activity
Potential

 
 
 
 
 
StocksRunner

Discover CRSP Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CRSP. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our CRSP Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CRSP Stock trends

CRSP Stock performance

CRSP Stock analysis

CRSP investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 
Post ×
 
0/666
joker